PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent eventsLaia Agell, Josep Lloreta|Modern Pathology|2010Cited by 51